SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-022141
Filing Date
2022-11-04
Accepted
2022-11-04 13:19:34
Documents
82
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eypt-20220930.htm   iXBRL 10-Q 3323686
2 EX-31.1 eypt-ex31_1.htm EX-31.1 17275
3 EX-31.2 eypt-ex31_2.htm EX-31.2 17740
4 EX-32.1 eypt-ex32_1.htm EX-32.1 7540
5 EX-32.2 eypt-ex32_2.htm EX-32.2 7557
  Complete submission text file 0000950170-22-022141.txt   11865261

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eypt-20220930_def.xml EX-101.DEF 258033
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eypt-20220930_lab.xml EX-101.LAB 551029
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eypt-20220930.xsd EX-101.SCH 71679
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eypt-20220930_pre.xml EX-101.PRE 411770
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eypt-20220930_cal.xml EX-101.CAL 61831
76 EXTRACTED XBRL INSTANCE DOCUMENT eypt-20220930_htm.xml XML 2487126
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51122 | Film No.: 221361464
SIC: 3826 Laboratory Analytical Instruments
Industrial Applications and Services